Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma

por Engesæter, Birgit, Engebraaten, Olav, Flørenes, Vivi Ann, Mælandsmo, Gunhild Mari
Publicado em 2012

Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening

por Hashim, Dana, Engesæter, Birgit, Baadstrand Skare, Gry, Castle, Philip E., Bjørge, Tone, Tropé, Ameli, Nygård, Mari
Publicado no Br J Cancer (2020)

hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma

por Fleten, Karianne G, Flørenes, Vivi Ann, Prasmickaite, Lina, Hill, Oliver, Sykora, Jaromir, Mælandsmo, Gunhild M, Engesæter, Birgit
Publicado no Cell Death Discov (2016)

Aldehyde Dehydrogenase (ALDH) Activity Does Not Select for Cells with Enhanced Aggressive Properties in Malignant Melanoma

por Prasmickaite, Lina, Engesæter, Birgit Ø., Skrbo, Nirma, Hellenes, Tina, Kristian, Alexandr, Oliver, Nina K., Suo, Zhenhe, Mælandsmo, Gunhild M.
Publicado em 2010

Impact of scheduled appointments on cervical screening participation in Norway: a randomised intervention

por Lönnberg, Stefan, Andreassen, Trude, Engesæter, Birgit, Lilleng, Rune, Kleven, Cecilia, Skare, Annelie, Johansson, Karin, Fredheim, Christina Stangeland, Tropé, Ameli
Publicado no BMJ Open (2016)

Psychological effect of cervical cancer screening when changing primary screening method from cytology to high‐risk human papilloma virus testing

por Andreassen, Trude, Hansen, Bo T., Engesæter, Birgit, Hashim, Dana, Støer, Nathalie C., Tropé, Ameli, Moen, Kåre, Ursin, Giske, Weiderpass, Elisabete
Publicado no Int J Cancer (2019)

Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma

por Magnussen, Gry Irene, Emilsen, Elisabeth, Giller Fleten, Karianne, Engesæter, Birgit, Nähse-Kumpf, Viola, Fjær, Roar, Slipicevic, Ana, Flørenes, Vivi Ann
Publicado no BMC Cancer (2015)

Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors

por Seip, Kotryna, Fleten, Karianne G., Barkovskaya, Anna, Nygaard, Vigdis, Haugen, Mads H., Engesæter, Birgit Ø., Mælandsmo, Gunhild M., Prasmickaite, Lina
Publicado no Oncotarget (2016)

Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis

por Slipicevic, Ana, Øy, Geir Frode, Rosnes, Anne Katrine Ree, Stakkestad, Øystein, Emilsen, Elisabeth, Engesæter, Birgit, Mælandsmo, Gunhild M., Flørenes, Vivi Ann
Publicado em 2013

Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study

por Engesæter, Birgit, van Diermen Hidle, Bianca, Hansen, Mona, Moltu, Pia, Staby, Kjersti Mangseth, Borchgrevink-Persen, Siri, Vintermyr, Olav K., Lönnberg, Stefan, Nygård, Mari, Janssen, Emiel A. M., Castle, Philip E., Christiansen, Irene Kraus
Publicado no BMC Infect Dis (2016)